Today, @SuzanneUSCC defended American free enterprise: “Society as a whole reaps the outsize benefits of market-driven innovations. Those who believe in free enterprise must stand up and say so."
Take a look: The state of American business is optimistic 👇https://t.co/KFZeD3Y1dw
With @IsabelleIcso, Director of International Policy @USChamber and a delegation from the US Chamber of Commerce. Discussing progress towards and deliverables for MC13, especially e-commerce moratorium, dispute settlement reform and TRIPS waiver for therapeutics and diagnostics.
Developing new medicines and vaccines can transform the way we prevent, treat, and cure disease. It’s a risky, unpredictable, but important journey. That’s why we’re #AlwaysInnovating
https://t.co/ShgZ8CBIiq
"Trade policy can empower innovators and creators to thrive in global markets or it can stop them in their tracks." - @KMAndersonDC via @USChamber
https://t.co/IZ1xzl3txK
@sdonnan I read Naked Economics by Charles Wheelan for grad school (and I’ve actually re-read it since then.) can’t recommend it highly enough! https://t.co/2aIaXuQWZg
Today, we approved oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. https://t.co/POFOIvvul8
Speaking about his retirement, Justice Stephen Breyer acknowledged some of the challenges facing the U.S. — and professed hope in the future of democracy.
Read his full remarks here 👇
https://t.co/BIylMXDP5Q
Driving home tonight, I thought about Republicans' floor speeches today on the "sanctity of life".
And how this concern for "life" apparently doesn't extend to the kids who were shot today in a school in Michigan.
So I turned the car around, and went to the Senate floor.
A Lilly medicine received permission for restricted emergency use to treat #COVID19 in eligible hospitalized patients in India. We’re donating medicine and pursuing royalty-free voluntary licensing agreements to accelerate manufacturing and distribution: https://t.co/gp10mPiQNg
ICYMI: @DrMichelleBIO penned an op-ed last week to explain how waiving #IP protections like patents would undermine innovators’ response to #COVID19 and future health emergencies. Read the full piece here: https://t.co/cyfFxQyrlr
"As a post-pandemic world nears — and we begin to prepare for future pandemics — bolstering America’s IP infrastructure will help equip us for whatever challenges lie ahead." - James Pooley
https://t.co/UeTVB5IuZC